Saudi Arabia and Russia: feuding oil powerhouses

What does the standoff between Saudi Arabia and Russia mean for oil prices and markets?

09 Mar 2020

A stand-off over production cuts between Saudi Arabia and Russia, the world's two largest oil producers by volume after the US, has sent oil prices plunging and had a ripple effect across markets.

So is this a structural break in the relationship between the two ex-US oil power brokers – or a short-term misunderstanding that can be rectified?

There is clearly deep frustration on both sides at how last week's OPEC+ meeting developed. Russia may be able to withstand lower oil prices significantly better than it could historically, but a very low oil price is not good for either Russia or Saudi Arabia.

In our view, developments do not completely preclude production cuts in the coming quarters, particularly given the strong relationship between Vladimir Putin, King Salman and Crown Prince Mohammed bin Salman.

And after recent price action, there is now scope for those cuts to surprise the market positively. But such a deal is far from a given. The worrying aspect is the 'tit for tat' production ramp up by Saudi Arabia and the apparent end of OPEC+ as a major driver of oil price stability.

Economic implications of plunging oil prices

These developments come at a time of already considerable investor fragility as the coronavirus' spread in the US and Europe accelerates. Given that fragility, the spillover from commodity markets is potentially significant.

Economically, the drop in oil prices reduces the spending power of a number of oil-producing countries – albeit that this is countered to a degree by the boost to the disposable income of global consumers and to the margins of major oil importers such as China and India. However, we believe that any boost is unlikely to be material in the short-term face of the coronavirus.

Both growth and inflation expectations are likely to be hit globally – with government bond yields sent to fresh all-time lows. The drop in prices is likely to hit the US, the world's largest exporter of oil, harder than elsewhere – leading to a drop in capital expenditure and employment from the economically important shale oil industry.

Potential impact of falling oil prices on credit is noteworthy

For highly-indebted oil producers in the US in particular, the fall in oil prices is not a question of lower short-term earnings, but a question of solvency. In part, this is what Russia wants: to exploit the current global situation and permanently remove some of the supply coming out of the US. There are therefore knock-on effects of the oil price drop for oil equipment manufacturers and to bank lenders to the US oil industry.

US High Yield credit spreads have widened quickly and significantly to reflect this. We expect them to stay wide without any deal between the Saudi Arabia and Russia.

Despite recent market movement, the energy sector still represents around 12% of US High Yield. Importantly, we believe that these issues are unlikely to be contained within the energy sector – and raise valid concerns about the wider credit universe and about market liquidity.

There is a well-documented potential mismatch between assets under management in passive high yield vehicles and dealer inventory in underlying bonds. 

With the coronavirus adding to liquidity concerns, these ingredients raise the prospect of exaggerated price moves if redemption flows in these high yield vehicles increase more significantly.

Outside of the specifics of the energy sector, the oil price developments represent an additional source of volatility that increases the short-term equity risk premium and is an additional weight on investor sentiment already hit by the coronavirus. Risk assets appear to have been slow to price in the risks to global growth.

We therefore do not see the drawdown in global equity markets and sharp drop in US Treasury yields as a significant over-reaction to the negative newsflow of the coronavirus or energy markets over recent days.

Further rate cuts expected

Looking forward we expect further cuts in policy rates and an expansion of central bank balance sheets across major economies including the US, UK, Eurozone and Japan in the coming days in response to the coronavirus growth shock and risks of contagion from the falling oil price. But the effectiveness of monetary policy is diminished, at least in the short-term, by the impact of the coronavirus on economic growth.

In our view it is therefore a step change in fiscal spending from major economies that holds the key to reinvigorating growth expectations and improving investor confidence. And if policy makers are able to ward off contagion and recession, there is scope for a very sharp rebound in economic growth and in risk assets given the benefits of loose monetary policy and a low oil price.

How are we positioning portfolios?

Within Global Equity markets, the collapse in the oil price has further reinforced the 'flight to safety' we have seen in markets with cyclical stocks underperforming defensive stocks.

Energy stocks are big components of Value indices and therefore Value has further underperformed growth. The risk-off environment has also put pressure on highly leveraged companies.

We are using such short term dislocation to increase holdings where shares have fallen below our estimates of long term value, while being mindful of the risk of further disruption. We are being especially sensitive to investing in companies where we believe the current uncertainty may impact their long term business models. Our experience has proven that such times present excellent potential opportunities to take advantage of over-reactions in markets.

For Fixed Income, we previously reduced credit risk and have positioned strategies to benefit from increased demand for high quality sovereign and corporate bonds. Specifically, we pared back our investment grade and high yield positions from last year and into January while maintaining a bias to long duration.

At this stage we do not anticipate making any material changes to positions.

We are, however, mindful of the fact that we are in totally unchartered territory and extra caution is therefore warranted.

Subscribe now

Perspectives matter. Tune in to our insights.

Views from our Alternatives team

UBS O'Connor is observing extreme levels of volatility in rates, credit and equities, creating significant risks and opportunities across all our strategies. From a historical perspective, we see a strong parallel for current market conditions with those observed in late 2015 / early 2016, where the market similarly dealt with extreme moves in oil and accelerating recession fears. While the early part of this risk aversion focused on just the recalibration of equities and rates, the second wave of de-risking extended to alternative strategies with especially notable unwinds happening in both the credit and merger arbitrage space. As the markets adjust and come to terms with the economic realities of both lower oil prices and the economic disruption related to COVID-19, investors are increasingly focused on policy alternatives to provide both monetary and fiscal support to the global economy. As with any high correlation, risk-off event, performance suffers short-term but longer-term opportunities abound as the market will inevitably begin its normalization over the next two to three weeks. UBS O'Connor is selectively adding risk in high quality investment grade bonds, lower risk merger arbitrage situations, and in single stocks where the risk sell-off has taken prices well below our assessment of their value relative to indices and other comparables.

From a UBS Hedge Fund Solutions perspective, it's worth noting that hedge funds are generally protecting capital in the period despite significant risk premium widening across markets. The historic volatility in US rates has driven some mark-to-market losses in Fixed Income Relative Value, but repo financing has been stable, enabling managers to hold positions. APAC has been a bright spot for performance as offshore China long / short hedge funds are positive to date in the month of March. We believe that the Energy sector is likely to go through a difficult period with escalated default activity. In addition to Covid-19 demand destruction and the OPEC driven oil selloff, ESG is a secular factor that is limiting the amount of bank financing and speculative capital for fossil fuel companies. We will likely see an interesting opportunity in energy credit as the "baby gets thrown out with bathwater." Finally, in our view much of the spread widening in Relative Value strategies, like merger arbitrage, is mark-to-market and likely to rebound.

COVID-19 is a risk to economies and real estate markets, particularly in Asia Pacific, but we believe that any impact will be short term if it is contained. There has been a dip in investment activity and share of international capital flows. We have seen interest rate cuts leading to yield falls in some markets, with real estate pricing around average versus index linked bonds. We do not see a big inflation risk and our analysis suggests that real estate offers suitable inflation protection.

More insights

Singapore Retail Investors

PLEASE READ THESE TERMS AND CONDITIONS CAREFULLY BEFORE PROCEEDING. BY UTILIZING THE WEBSITE AND PAGES THEREOF LOCATED AT WWW.UBS.COM/AM-SG ("WEBSITE"), YOU ACKNOWLEDGE THAT YOU HAVE READ THESE TERMS AS WELL AS THE GLOBAL TERMS OF USE (collectively "TERMS") AND THAT YOU AGREE TO BE BOUND BY THEM. IF YOU DO NOT AGREE TO ALL OF THE TERMS OF THIS AGREEMENT, YOU ARE NOT AN AUTHORIZED USER OF THESE SERVICES AND YOU SHOULD NOT USE THIS WEBSITE.

This website is not intended for and should not be accessed by persons located or resident in any jurisdiction where (by reason of that person's nationality, domicile, residence or otherwise) the publication or availability of this website is prohibited or contrary to local law or regulation or would subject any UBS entity to any registration or licensing requirements in such jurisdictions. It is your responsibility to be aware of, to obtain all relevant regulatory approvals, licenses, verifications and/or registrations under, and to observe all applicable laws and regulations of any relevant jurisdiction in connection with your entrance to this website. Each investment product and service referred to on this website is intended to be made available only to residents in Singapore.

UBS reserves the right to change, modify, add or remove content on the website as well as these terms at any time for any reason without notice. Such changes shall be effective immediately upon posting. You acknowledge that by accessing our website after we have posted changes to these terms, you are agreeing to these terms as modified.

The materials on this Website are distributed by UBS Asset Management (Singapore) Ltd (company registration number: 199308367C), which is licensed by Monetary Authority of Singapore ("MAS") in Singapore pursuant to the Securities and Futures Act (Chapter 289 of Singapore). UBS Asset Management (Singapore) Ltd is part of the Asset Management business division of UBS Group AG. UBS Asset Management (Singapore) Ltd together with UBS Group AG and its group companies shall collectively be referred to as "UBS".

The information contained in this Website has been prepared and is intended for general circulation. The information does not constitute advice and does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. The investment services or products referred to in this Website may not be suitable for all investors. UBS recommends that you independently evaluate particular investments and strategies and seek independent advice from a financial adviser regarding the suitability of such investment products, taking into account your specific investment objectives, financial situation and particular needs, before making a commitment to purchase any investment products. Investment involves risks. You should be aware that investments may increase or decrease in value and that past performance is not indicative of future performance.

The information contained in this Website is not an offer to buy or sell or the solicitation of an offer to buy or sell any investment product or to participate in any particular trading strategy. UBS, its officers and/or employees may have interests in any of the investment products referred to on this Website by acting in various roles. UBS, its officers and/or employees may receive fees, commissions or other benefits for acting in those capacities. In addition, UBS, its officers and/or employees may buy or sell investment products as principal or agent and may effect transactions which are not consistent with the information set out in this Website.

You fully understand and agree that, by making available this Website, UBS should not be construed as making: (a) any endorsement of any investment product referred to in this Website; (b) any representation that UBS has performed any due diligence on any investment product referred to in this Website; or (c) any representation that the information in this Website is complete, accurate, clear, fair and not misleading. The use or reliance on any such information contained in this Website is at your own risk and any losses which may be suffered as a result of you entering into any investment are for your account and UBS shall not be liable for any losses arising from or incurred by you in connection therewith. UBS is not responsible or liable for the accuracy and completeness of any such information or the performance or outcome of any investment made by you after receipt of such information, irrespective of whether such information was provided at your request.

Using, copying, redistributing or republishing any part of this Website without prior written permission from UBS is prohibited. Any statements made regarding investment performance objectives, risk and/or return targets shall not constitute a representation or warranty that such objectives or expectations will be achieved or risks are fully disclosed. The information and opinions contained in this Website is based upon information obtained from sources believed to be reliable and in good faith but no responsibility is accepted for any misrepresentation, errors or omissions. All such information and opinions are subject to change without notice. A number of comments in this Website are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a reflection of UBS’s judgment at the time this document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.

UBS does not hold out any of its officers and/or employees as having any authority to advise you, and UBS does not purport to advise you on any investment product. Any investment will be made at your sole risk and UBS is not and shall not, in any manner, be liable or responsible for the consequences of any investment.

This Website and its contents are provided on an “as is” and “as available” basis. UBS does not warrant: (a) the accuracy, timeliness, adequacy commercial value or completeness of this Website or its contents, and expressly disclaims any liability for errors, delays or omissions in the contents, or for any action taken in reliance on the contents; (b) that your use of and/or access to this Website or its contents, will be uninterrupted, timely, secure or free from errors or that any identified defect will be corrected; (c) that this Website or any content will meet your requirements or are free from any virus or other malicious, destructive or corrupting code, agent, program or macros; (d) that any information, instructions or communications posted or transmitted by you through this Website is secure and cannot be accessed by unauthorised third parties; and (e) that use of the contents in this Website by you will not infringe the rights of any third parties. No warranty of any kind, implied, express or statutory, including but not limited to the warranties of non-infringement of third party rights, title, merchantability, satisfactory quality or fitness for a particular purpose and freedom from computer virus or other malicious, destructive or corrupting code, agent, program or macros, is given in conjunction with this Website.

You hereby agree to indemnify UBS and any of its officers, employees or agents against, and to keep UBS and any of its officers, employees or agents harmless from, any claims (actual and threatened), settlement sums, liability, loss, damages, costs (including solicitor and client costs and expenses (legal or otherwise)), charges, expenses, actions, proceedings, whether foreseeable or not which we may sustain, suffer or incur, directly or indirectly out of or in the course of or in connection with any the following: (a) any use of this Website or the contents by you, or any part thereof; (b) UBS having made available the Website; (c) any breach of these Terms by you, however arising; or (d) any negligence, act or omission, wilful default, unlawful act, fraud and/or misconduct on your part or violation of any rights of another person or entity by you.

The funds referred to in this Website have been authorised or recognised by the MAS for sale to the public in Singapore (the “Funds”). Copies of the registered Singapore prospectuses ("Prospectuses") referred to in this Website have been lodged with and registered by the MAS. The MAS assumes no responsibility for the contents of the Prospectuses. The registration of the Prospectuses by the MAS does not imply that the SFA or any other legal or regulatory requirements have been complied with.

MAS registration is not a recommendation or endorsement of a Fund nor does it guarantee the commercial merits or performance of such Fund. It does not mean that a Fund is suitable for all investors nor is it an endorsement of its suitability for any particular investor or class of investors. UBS Asset Management (Singapore) Ltd has been appointed as the representative for the Funds in Singapore for the purposes of performing administrative and other related functions relating to the offer of Shares under Section 287 of the Securities and Futures Act, Chapter 289 of Singapore (the "SFA") and such other functions as the MAS may prescribe.

You may not assign your rights under the Terms without our prior written consent. UBS Asset Management (Singapore) Ltd may assign our rights under the Terms to any third party.

No person or entity who is not a party to the Terms shall have any right under the Contracts (Rights of Third Parties) Act, Chapter 53B of Singapore or other similar laws to enforce any term of the Terms regardless of whether such person or entity has been identified by name, as a member of a class or as answering a particular description. For the avoidance of doubt, this shall not affect the rights of any permitted assignee or transferee of the Terms.

These Terms shall be governed by, and shall be construed in accordance with, the laws of Singapore. The courts of Singapore shall have exclusive jurisdiction to hear and determine any suit, action or proceeding, and to settle any disputes, which may arise out of or in connection with these Terms and, for such purposes, you agree to submit  to the jurisdiction of the courts of Singapore. Each party hereby waives any objection which it might at any time have to the courts of Singapore being nominated as the forum to hear and determine any proceedings and to settle any disputes and agrees not to claim that the courts of Singapore are not a convenient or appropriate forum.

© UBS 2020 - the key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

Reset